Extrapancreatic action of truncated glucagon-like peptide-I in Otsuka Long-Evans Tokushima Fatty rats, an animal model for non-insulin-dependent diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 46, Issue 7, 1997, Pages 745-749

  Mizuno, Akira ^a   Kuwajima, Masamichi ^b   Ishida, Kaori ^b   Noma, Yoshihiko ^b   Murakami, Takashi ^b   Tateishi, Kayoko ^b   Sato, Izumi ^b   Shima, Kenji ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE UTILIZATION; HYPERINSULINEMIA; IMMUNOREACTIVITY; INSULIN LIKE ACTIVITY; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS FUNCTION; PRIORITY JOURNAL; RAT;

EID: 0030804882     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90117-7     Document Type: Article

References (27)

1. Gutniak M, Orskov C, Holst JJ, et al: Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316-1322, 1992
2. Yamato E, Noma Y, Shima K, et al: Suppression of synthesis and release of glucagon by glucagon-like peptide 1 (7-36) amide without effect on mRNA level in isolated rat islets. Biochem Biophys Res Commun 167:431-437, 1989
3. Villanureva-Penacarrillo ML, Alcantra AL, Clemente F, et al: Potent glycogenic effect of GLP-1 (7-36) amide in rat skeletal muscle. Diabetologia 37:1163-1166, 1994
4. Josephine ME, Chahrzad MR, Jesse R, et al: Glucagon-like peptide-1 (7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3T3-L1 adipocytes: One of several potential extrapancreatic sites of GLP-1 action. Endocrinology 135:2070-2075, 1994
5. Oben J, Morgan L, Marks J, et al: Effect of the entero-pancreatic hormones, gastric inhibitory peptide and glucagon-like polypeptide-1 (7-36) amide, on fatty acid synthesis in explants of rat adipose tissue. J Endocrinol 130:267-272, 1991
6. D' Allesio DA, Kahn SE, Ensinck JW, et al: Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin independent glucose disposal. J Clin Invest 93:2263-2266, 1994
7. Kawano K, Hirashima T, Natori T, et al: Spontaneous long-term hyperglycemic rat with diabetic complications, Otsuka-Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41:1422-1428, 1992
8. Rossetti L, Smith D, Schulman GI, et al: Correlation of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79:1510-1515, 1987
9. Somogyi M: Determination of blood sugar. Biol Chem 160:69-73, 1945
10. Steele R: Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-430, 1959
11. Ferre P, Leturque A, Burnol AF, et al: A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of anesthetized rat. Biochem J 228:103-110, 1985
12. James DE, Burleigh KM, Kragen EW: In vivo glucose metabolism in individual tissues of rats. J Biol Chem 261:6366-6374, 1986
13. Kraegen EW, James DE, Jenkins AB, et al: Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248:E353-E362, 1985
14. Nishino T, Kodaira T, Shima K, et al: Glucagon radioimmunoassay with use of antiserum to glucagon C-terminal fragment. Clin Chem 27:1690-1697, 1981
15. Tateishi K, Shima K, Matsuoka Y, et al: Glucagon-like peptide-1 (GLP-1) molecular forms in human pancreatic endocrine tumors resemble those in intestine rather than pancreas. Diabetes Res Clin Pract 25:43-49, 1994
16. Roberge JN, Brubaker PL: Regulation of intestinal proglucagonderived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 133:233-240, 1993
17. Shima K, Hirota M, Ohboshi C: Effect of glucagon-like peptide-1 on insulin secretion. Regul Pept 22:245-252, 1988
18. Shima K, Tanaka R, Sawazaki N, et al: Relationship between secretory capacity of pancreatic A cell and of B cell. Horm Metab Res 11:451-452, 1979
19. Ishida K, Mizuno A, Shima K, et al: Plasma glucagon responses to insulin-induced hypoglycemia and arginine in spontaneous non-insulin-dependent diabetes mellitus (NIDDM) rats, Otsuka Long Evans Tokushima Fatty (OLETF) strain. Acta Endocrinol (Copenh) 129:585-593, 1993
20. Blackmore PF, Mojsov S, Habener JF, et al: Absence of insulinotropic glucagon-like peptide-1(7-37) receptors on isolated rat liver hepatocytes. FEBS Lett 283:7-10, 1991
21. Ghiglione M, Blazquez E, Bloom SR, et al: Glucagon-like peptide-1 does not have a role in hepatic carbohydrate metabolism. Diabetologia 28:920-921, 1985
22. Shimizu I, Hirota M, Shima K, et al: Effect of glucagon-like peptide-1 and -2 on glycogenolysis in cultured rat hepatocytes. Biomed Res 7:431-436, 1986
23. Murayama Y, Kawai K, Yamashita K, et al: Glucagon-like peptide-1 (7-37) does not stimulate either glycogenolysis or ketogenesis. Endocrinol Jpn 37:293-297, 1990
24. Campos RV, Lee YC, Drucker DJ: Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-I in the mouse. Endocrinology 134:2156-2164, 1994
25. Valverde I, Morales M, Clemente F, et al: Glucagon-like peptide I: A potent glycogenic hormone. FEBS Lett 349:313-316, 1994
26. Valverde I, Merida E, Delgado E, et al: Presence and characterization of glucagon-like peptide-1 (7-36) amide receptors in solubilized membranes of rat adipose tissue. Endocrinology 132:75-79, 1993
27. Oben J, Morgan L, Fletcher J, et al: Effect of enteropancreatic hormones, gastric inhibitory polypeptide and glucagon-like peptide-1 (7-36) amide, on fatty acid synthesis in expiants of rat adipose tissue. J Endocrinol 130:267-272, 1991